Tulasi Yadati
Maastricht, LI, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Inhibition of intracellular versus extracellular cathepsin D differentially alters the liver lipidome of mice with metabolic dysfunction-associated steatohepatitis.
Journal: The FEBS journal
Published: March 14, 2024
Cysteamine Decreases Low-Density Lipoprotein Oxidation, Causes Regression of Atherosclerosis, and Improves Liver and Muscle Function in Low-Density Lipoprotein Receptor-Deficient Mice.
Journal: Journal of the American Heart Association
Published: September 08, 2021
Pro-Inflammatory Implications of 2-Hydroxypropyl-β-cyclodextrin Treatment.
Journal: Frontiers in immunology
Published: May 28, 2021
Inhibition of Extracellular Cathepsin D Reduces Hepatic Lipid Accumulation and Leads to Mild Changes in Inflammationin NASH Mice.
Journal: Frontiers in immunology
Published: March 03, 2021
OxLDL as an Inducer of a Metabolic Shift in Cancer Cells.
Journal: Journal of Cancer
Published: November 23, 2020
The Ins and Outs of Cathepsins: Physiological Function and Role in Disease Management.
Journal: Cells
Published: June 22, 2020
Inhibiting Extracellular Cathepsin D Reduces Hepatic Steatosis in Sprague⁻Dawley Rats †.
Journal: Biomolecules
Published: March 26, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026